Beilei Wang
Hefei, 230031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Discovery of pyrazole derivative IHMT-140 as a pancreatic cancer therapeutic agent via dual mechanisms DDR1 inhibition and methuosis induction.
Journal: Journal of advanced research
Published: February 14, 2026
Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of Inflammatory Bowel Disease.
Journal: Journal of medicinal chemistry
Published: October 13, 2025
Discovery of a 1H-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease.
Journal: Journal of medicinal chemistry
Published: October 13, 2025
Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: August 27, 2025
Discovery of IHMT-15130 as a Highly Potent Irreversible BMX Inhibitor for the Treatment of Myocardial Hypertrophy and Remodeling.
Journal: ACS chemical biology
Published: May 19, 2025
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies.
Journal: Journal of medicinal chemistry
Published: April 08, 2025
Discovery of Pyrazolo[1,5-a]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 20, 2024
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy.
Journal: Acta pharmaceutica Sinica. B
Published: March 15, 2023
Pharmacological inhibiting STAT5 for the treatment of FLT3-ITD-positive acute myeloid leukemia with triciribine phosphate monohydrate.
Journal: MedComm
Published: February 25, 2023
Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes.
Journal: Journal of medicinal chemistry
Published: August 29, 2022
Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus.
Journal: Signal transduction and targeted therapy
Published: July 31, 2022
Silk fibroin/chitosan coating with tunable catalytic nitric oxide generation for surface functionalization of cardiovascular stents.
Journal: International journal of biological macromolecules
Published: July 27, 2022
Last Updated: 09/26/2026